Fisher Diagnostics is recalling 6,086 units of Pacific Hemostasis Thromboplastin-D because the outer box label contains an incorrect International Sensitivity Index (ISI) value. This laboratory reagent is used to perform prothrombin time tests and factor assays to evaluate blood clotting. Using an incorrect ISI value can lead to inaccurate test results, which may affect clinical decisions and patient treatment. No injuries or incidents have been reported at this time.
The incorrect label value could cause laboratories to miscalculate test results, potentially leading to incorrect dosing of blood-thinning medications or a failure to identify clotting disorders. This poses a moderate risk to patient safety depending on the clinical setting.
Quantity: 4,387 units; Recall #: Z-1502-2025
Quantity: 1,699 units; Recall #: Z-1503-2025
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.